Nevro (NVRO) Misses Q4 EPS by 11c, Revenues Beat; Offers FY19 Revenue Views Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. DASH
9. MA
10. FND

Go back to Nevro (NVRO) Misses Q4 EPS by 11c, Revenues Beat; Offers FY19 Revenue Views Below Consensus

Nevro Reports Fourth Quarter and Full Year 2018 Financial Results

February 21, 2019 4:10 PM EST

REDWOOD CITY, Calif., Feb. 21, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today reported financial results for the fourth quarter and full year ended December 31, 2018.

2018 Accomplishments and Recent Highlights

Hired Michael Carter as Vice President, Global Sales to lead worldwide sales organization Launched Senza II: a smaller-footprint, advanced battery system with 10+ year life, and subsequently received FDA Approval for Conditional Full Body MRI Published a global registry of long-term... More